Early research (Phase 1)Study completedNCT05435638
What this trial is testing
Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases
Who this might be right for
Punctate Palmoplantar Keratoderma Type 1Pachyonychia Congenita
Kamari Pharma Ltd 14